Directors’ Dealings | 18 December 2023 11:20


Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, buy


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
18.12.2023 / 11:20 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Prof. Dr.
First name: Andreas
Last name(s): Pahl

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Heidelberg Pharma AG

b) LEI
391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A11QVV0

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
3.3800 EUR 676.00 EUR
3.3700 EUR 3,370.00 EUR
3.3800 EUR 3,042.00 EUR
3.3800 EUR 1,183.00 EUR
3.3800 EUR 1,859.00 EUR

d) Aggregated information
Price Aggregated volume
3.3767 EUR 10,130.0000 EUR

e) Date of the transaction
2023-12-15; UTC+1

f) Place of the transaction
Name: Xetra
MIC: XETR


18.12.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

End of News EQS News Service

show this